
Warning over TikTok filming by hospital patients
Patients who film their own medical treatment for TikTok or Instagram could be putting themselves and NHS staff at risk, the Society of Radiographers (SoR) has warned. The trade union's annual conference heard that more patients were videoing their procedures on mobile phones, often without asking permission. This could distract staff or make them feel uncomfortable and anxious, the society said.Sharing material on social media also risks publicising the private medical data of other people who may be in the same room or area of the hospital.
"I had one patient whose relative started filming while I was trying to set up," said Ashley d'Aquino, a therapeutic radiographer from London. "It wasn't the right time - I was trying to focus on delivering the treatment."Ms d'Aquino, who is also a local union representative, said she had recently been contacted by other colleagues in a similar situation. "We had a member of staff who agreed to take photos for a patient," she said. "When the patient handed over her phone, the member of staff saw that the patient had also been covertly recording her, to publish on her cancer blog."
Most NHS staff wear identity badges and their names and job titles may be visible on videos posted online. The union said another of its members, a department assistant from the south coast of England, was inserting a cannula as part of a cancer procedure, when the patient's 19-year old daughter started filming on her phone. "She thought it would be entertaining on social media but she didn't ask permission," said the member of staff. "I spent the weekend afterwards worrying: did I do my job properly? I know I did, but no-one's perfect all of the time," she added."I don't think I slept for the whole weekend."
NHS 'needs policies'
Ms d'Aquino said there were valid reasons for patients to record the audio of medical consultations - so they could listen back to the detail, for example. "The difficulty is that our phones have become so much a part of our day-to-day life that recording and sharing has become second nature," she added. Dean Rogers, the director of strategy at the SoR, is calling for NHS trusts to have clear policies in place that stop patients from filming without permission."As healthcare professionals, we need to think: does that recording breach the confidentiality of other patients? Does it breach our ability to deliver care?" he said."There are hospital trusts that have very good policies around patients taking photos and filming procedures but this is something all trusts need to have in place."Prof Meghana Pandit, co-national medical director at NHS England, said it was vital that, if patients want to record any part of NHS care, they discuss it with staff first and it remains for their personal use only."Recording other patients inadvertently and without their permission risks breaching patient confidentiality – the information and treatment provided to other patients on NHS premises should never be recorded, let alone posted to social media," she added.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Wales Online
28 minutes ago
- Wales Online
25 UK holidaymakers fell ill on 'nightmare' five-star holiday
25 UK holidaymakers fell ill on 'nightmare' five-star holiday They have reported dirty plates, flies and raw food before dozens fell ill Holidaymakers say some of the food was not cooked properly A group of 25 British tourists are seeking legal action after falling seriously ill on "nightmare" holidays to a luxury five-star resort in Cape Verde. Hotel guests said their dream trips quickly turned into holidays from hell after they suffered gastric illnesses while staying in Boa Vista. Holidaymakers reported seeing birds, flies and even cats around the buffet area, which also served "raw and undercooked" food along with "dirty crockery and cutlery." One NHS worker who spent £3,000 on a trip to celebrate early retirement was left hospitalised after being stuck down with Sharon Burrow said she still suffers from complications eight months on after the luxury break turned into "one of the worst experiences of her life". Another guest, Penny Robson had to be given antibiotics after coming down with gastric symptoms including bloating, diarrhoea, nausea and stomach cramping. Sharon Burrows The pair are among 25 people who have now instructed lawyers to investigate after raising concerns about hygiene standards at the resort. Sharon, 56, of Ashton-under-Lyne, Greater Manchester, travelled to Cape Verde for a ten day break on September 20, 2024. But around five days into the holiday, she started to suffer from aches and pains, and a fever before experiencing stomach cramps and diarrhoea. Sharon visited A&E upon her return to the UK and tests confirmed she had and shigella. She said doctors suspected she contracted the infection on holiday. Article continues below The mental health worker said: 'I was unwell for nearly three weeks and it was one of the worst experiences of my life. 'I was in so much pain and completely drained - it felt like my body just shut down. I'd been concerned about hygiene at the hotel. Food was served at room temperature and new food was added to existing food. "I saw dirty crockery, cats in and around the restaurant and empty plates attracting flies were left on tables. I feel completely let down and while it's too late for me the least I feel I deserve is answers and to raise awareness of what I've been through so hopefully others don't have to.' Penny, a 55-year-old paramedic from London, travelled to the resort in September 2023 and paid £2,000 for the week-long break with her friend. She was left requiring medical treatment at the resort, including antibiotics and electrolytes, after she fell poorly five days into the holiday. Penny Robson Penny had to cancel two pre-paid excursions, including a stargazing trip and a private island tour. She raised concerns about the food hygiene at the resort, reporting that food was often served lukewarm, left uncovered, and exposed to birds and flies. On one occasion, she picked up a piece of chicken from the buffet and discovered it was raw. Since returning home, Penny says she has experienced ongoing anxiety and the illness has had a lasting impact on her confidence and wellbeing. Penny said: 'I was looking forward to my holiday and had saved for months. However, the excitement for the holiday quickly disappeared when I started feeling unwell. It completely ruined what should have been a relaxing time. I've never felt so vulnerable while abroad. 'I'm very cautious now regarding where I would book a holiday. This has affected my choices and I travel much shorter distances to Europe as I don't feel confident travelling to further afield places. 'I no longer trust my body and if I ever eat out I constantly worry about food and how it's prepared. I just want answers as to how my holiday became a nightmare.' Law firm Irwin Mitchell is currently representing more than 1,400 holidaymakers who suffered serious illnesses linked to holidays in Cape Verde since 2022. Jatinder Paul, the international serious injury lawyer representing those who have fallen ill, said: 'This is yet another resort in Cape Verde that has come under the spotlight following reports of serious illness. 'We're already representing more than 1,400 British holidaymakers who have suffered gastric illness linked to holidays on the islands over the last three years. Illnesses like are serious and can lead to long-term health complications. It's vital that if any issue are identified, swift action is taken to eradicate the risks to other holidaymakers. 'While nothing can make up for their ordeals, this latest group we represent understandably want answers. They booked what they hoped would be luxury holidays, but the first-hand accounts we've heard about their holiday were anything but luxury. Article continues below 'As part of our investigations, we would be interested in hearing from other guests staying at the hotel at the same time as this group.' The resort has been contacted for comment.


Daily Mail
37 minutes ago
- Daily Mail
Weight loss jabs like Mounjaro now linked to more than a HUNDRED deaths, the UK's drug watchdog confirms
Slimming jabs like Mounjaro and Wegovy have been linked to more than 100 deaths in Britain, it was revealed today. None of the fatalities, which have all been reported since the jabs were licensed for use in the UK, are proven to have been caused directly by the drugs. However, health chiefs tasked with policing the safety of medicines admit reports of side effects indicate 'a suspicion' they may have been to blame. A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to and including May 29. These are based on patients' families or healthcare workers informing the MHRA of a suspected fatal reaction to the drugs, known as glucagon-like peptide-1 receptor agonists (GLP-1RAs). It comes just months after the death Scottish nurse Susan McGowan, 58, who experienced multiple organ failure, septic shock and pancreatitis after taking just two doses of Mounjaro. Hers is the only confirmed fatality linked to the jabs in the UK. But it comes at a time when ministers are planning to rollout the jabs—described as game changers in the fight against obesity— to even more Britons. The deaths may also be caused by underlying medical conditions or other medications taken at the same time and therefore can be coincidental the MHRA told trade magazine Chemist+Druggist. Officials use the MHRA's 'Yellow Card' database, set-up in the wake of the 1960s thalidomide scandal, to track the safety of medications currently in use in Britain. Although almost impossible to prove, the system allows doctors, pharmacists and patients to report adverse reactions they believe are linked to medications and allows officials to uncover potential patterns. The weight-loss medication linked to the most deaths, in the system was liraglutide—sold under the brand name Saxenda—with 37 reports of a fatal outcome. In second place was tirzepatide—sold as Mounjaro and once hailed the 'King Kong' of slimming jabs—with 33 deaths. And in third place was semaglutide—the active ingredient in the weight loss jab Wegovy as well diabetes drug Ozempic—which was linked to 30 deaths. A further seven reports were liked to dulaglutide—known as Trulicity—and five to lixisenatide—which has the trade name Lyxumia. Of the total fatal reports, 32 involved jabs indicated for 'weight management alone or 'only licensed for weight management—Mounjaro, Saxenda, Wegovy'. Meanwhile, 40 reports related to drugs with an indication for 'diabetes alone'. Another nine referred to patients getting the jab for 'both weight management or diabetes'. While 30 reported a fatal outcome 'with an indication other than weight management or diabetes, or where no indication has been reported', the watchdog told Chemist+Druggist. Last year, medics warned they were seeing a wave of patients of healthy weight taking the drugs in a bid to become 'beach-body ready'. Such patients, mostly young women, were landing in A&E after obtaining the drugs online under false pretences. Currently, patients can obtain the drugs from many chemists by filling in online forms with details of their weight and height and submitting photographs of themselves. However, experts and organisations such as the Society for Acute Medicine have called for tighter restrictions on how Ozempic, Mounjaro and other weight-loss products are prescribed. A spokesperson for Lilly UK, the makers of Mounjaro, said patient safety is its 'top priority'. It added: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.' 'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.' There has been growing concern after reports of side effects from the drugs. These include including nausea, vomiting, diarrhoea, bone fractures, tooth damage, severe anxiety and depression. Earlier this month, women reported terrifying mental health side effects after using Mounjaro. The jab, along with similar treatments such as Ozempic and Wegovy, can help patients lose up to 15 per cent of their body weight in a year.


STV News
an hour ago
- STV News
Genetic testing study 'could help personalise treatments for patients'
A new study aims to show how genetic testing could help personalise treatments by boosting medication response and reducing harmful side effects. The landmark trial will recruit up to 4,000 patients over the next two years in the NHS Greater Glasgow and Clyde area, to investigate how an individual's genetic profile affects their response to 60 common medications. It is hoped the Phoenix Study will to lead to wider implementation of genetic testing across Scotland, making 'precision medicine' routine, for the first time. Researchers hope it will pave the way for tailored prescribing across cardiology, stroke, surgery, orthopaedics, geriatrics, gynaecology, ENT, rheumatology, respiratory, neurology, psychiatry and other specialities. The trial will take place at the Queen Elizabeth University Hospital (QEUH) in Glasgow. Pharmacogenomics (PGx) – the study of how genes influence individual responses to drugs – has not been routinely used in clinical practice in the UK, amid hopes evidence will lead to change. Genetic test results will be sent to clinicians, allowing for treatment decisions to be adjusted, and patients will be followed up regularly to monitor the effects of any changes, to ensure they receive the highest standard of care. Patients will undergo a simple genetic test to analyse their DNA and the results, returned within days, will help doctors determine whether each patient is receiving the most suitable drug and dosage based on their genetic make-up. Around 15% are expected to carry genetic variants that may reduce the effectiveness of a medication or increase the risk of side-effects. In some cases, the prescribed drug may be ineffective, or a different dosage may be needed. The trial is open to adult in-patients in the QEUH and patients will be randomly assigned to either receive the pharmacogenomic test immediately, or at three months, which will allow the researchers to establish evidence of benefit. Without prior testing, these issues can go unnoticed, often leading to a trial-and-error approach to treatment, according to researchers. It is led by Sandosh Padmanabhan, Pontecorvo chair of Pharmacogenomics at the University of Glasgow, in partnership with the University of Glasgow's Living Laboratory, the NHSGGC-hosted West of Scotland Innovation Hub, and industry partners MyDNA and Agena Bioscience. Patient Eric Balish was asked to take part by consultants, after having a heart attack and subsequent surgery. He was immediately prescribed clopidogrel, one of the 60 drugs included in the study, but has since had his medication changed a number of times. Mr Balish said: 'I knew a bit about personalised medicine previously, and so when I was asked to take part in the Phoenix Study I was happy to do it. 'If you're asked to participate and support long-term research like this, then it's no great hardship to give something back and just do the right thing. I am hopeful my information can be of use to the trial and in the future.' Prof Padmanabhan, a consultant at the QEUH, said: 'Physicians and pharmacists increasingly recognise that PGx-informed prescribing and dispensing improves both the efficacy and safety of drug treatment. 'The primary goal of this trial is to evaluate the clinical and health-economic impact of PGx-guided prescribing. 'Specifically, we want to determine if a PGx-guided approach to prescribing can significantly reduce the incidence and severity of drug related side-effects and/or treatment failures. 'This evaluation will compare the outcomes of participants who receive PGx-guided medication management to those receiving standard care.' Dr Katriona Brooksbank, research and innovation lead for NHSGGC and the West of Scotland Innovation Hub, said: 'We are incredibly excited to be supporting this trial, which could have a major impact on the treatments patients are prescribed based on their own genetics. 'It will put precision medicine into action as researchers look to determine how a person's own genetic make-up can affect the drugs they are given as treatments. 'This could allow clinicians to reduce adverse reactions and side effects, ensuring the best possible outcomes for patients.' Allan Sheffield, co-founder of MyDNA, said: 'For MyDNA, the Phoenix Study embodies the future of healthcare. 'Our unique combination of pharmacogenomic clinical decision support and in-house Gene by Gene accredited testing empowers clinicians to move beyond guesswork. 'This trial will demonstrate the profound impact of precision medicine, paving the way for a future where this approach routinely drives better patient outcomes.' Get all the latest news from around the country Follow STV News Scan the QR code on your mobile device for all the latest news from around the country